DUBLIN--(BUSINESS WIRE)--The "Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The cell analysis market is projected to reach USD 22.75 billion by 2024 from USD 16.05 billion in 2019, at a CAGR of 7.2%.
Growth in this market is driven by the increasing government funding for cell-based research and the rising incidence of chronic and infectious diseases. However, the high cost of cell analysis instruments and the dearth of skilled professionals are expected to hamper the growth of this market to a certain extent in the coming years.
Geographically, the cell analysis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the cell analysis market. Factors such as the presence of a favorable business environment, growing government support through funds and grants, growing number of research activities, rising number of drug discovery initiatives by pharmaceutical & biotechnology companies in the US, and the strong presence of key players in this region are driving the growth of the cell analysis market in North America.
This report provides a detailed picture of the global cell analysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, process, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
In 2018, Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson, and Company (US), Merck KGaA (Germany), and GE Healthcare (US) dominated the cell analysis market.
Other players in this market include Agilent Technologies, Inc. (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), Promega Corporation (US), Tecan Group (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss (Germany), Bio-Rad Laboratories Inc (US), and Sysmex Corporation (Japan).
For more information about this report visit https://www.researchandmarkets.com/r/yjrm6c
